- Home
- FKWL vs ESLA Comparison
FKWL vs ESLA Comparison
Compare FKWL & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FKWL | ESLA |
|---|---|---|
| Founded | 1981 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 48.9M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | FKWL | ESLA |
|---|---|---|
| Price | $4.53 | $1.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $16.00 |
| AVG Volume (30 Days) | 11.6K | ★ 175.8K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $45,508,949.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.05 | N/A |
| 52 Week Low | $3.67 | $0.73 |
| 52 Week High | $7.45 | $3.15 |
Technical Indicators
Market Signals| Indicator | FKWL | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 44.52 |
| Support Level | $4.41 | $1.86 |
| Resistance Level | $4.65 | $2.16 |
| Average True Range (ATR) | 0.14 | 0.30 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 58.81 | 28.00 |
Price Performance
Historical ComparisonAbout FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.